{"id":"W4386346756","doi":"10.1177/10781552231199048","title":"Utilization and toxicity patterns of 2-weekly (Q2W) versus 4-weekly (Q4W) nivolumab for treatment of adjuvant and metastatic melanoma at BC cancer","year":2023,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Dosing; Medicine; Incidence (geometry); Nivolumab; Adverse effect; Cancer; Internal medicine; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006397212,0.0001354109,0.0005933983,0.00017222,0.00006028348,0.00000606483,0.00005144405,0.00004847719,0.0001363276],"category_scores_gemma":[0.000255286,0.000104873,0.0001231752,0.0001590729,0.00009773192,0.0002488361,0.00002448208,0.00008122729,6.847536e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003997417,"about_ca_system_score_gemma":0.0004169191,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004382104,"about_ca_topic_score_gemma":0.0001350047,"domain_scores_codex":[0.9986956,0.0001768567,0.0006097793,0.0001425689,0.0002102975,0.0001649306],"domain_scores_gemma":[0.9969143,0.001417158,0.001139055,0.00009262552,0.0003350571,0.0001017923],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.1769237,0.002190972,0.02948644,0.0006754681,0.005478811,0.0003375566,0.003582089,0.00002330259,0.2104162,0.00001685356,0.005197063,0.5656716],"study_design_scores_gemma":[0.1285499,0.03860488,0.05473708,0.000316015,0.008808143,0.001961809,0.004515697,0.001708408,0.2249303,0.00002705788,0.535548,0.0002927307],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9843185,0.006829548,0.00009845473,0.007478296,0.0005759621,0.0004512462,0.00007969329,0.000006920596,0.0001614143],"genre_scores_gemma":[0.9487074,0.04951691,0.0008440882,0.0002962819,0.0001414787,0.00002377853,0.00001171253,0.00001890884,0.0004394647],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5653788,"threshold_uncertainty_score":0.4276599,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.162866911929307,"score_gpt":0.4656701600391103,"score_spread":0.3028032481098033,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}